Skip to main content

PUREVAX Feline 4 (0.5 mL)

This page contains information on PUREVAX Feline 4 (0.5 mL) for veterinary use.
The information provided typically includes the following:
  • PUREVAX Feline 4 (0.5 mL) Indications
  • Warnings and cautions for PUREVAX Feline 4 (0.5 mL)
  • Direction and dosage information for PUREVAX Feline 4 (0.5 mL)

PUREVAX Feline 4 (0.5 mL)

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health



Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine

Modified Live Virus, Modified Live Chlamydia

PUREVAX Feline 4 (0.5 mL) Indications

This product has been shown to be effective for the vaccination of healthy cats 6 weeks of age and older against feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci. The duration of immunity has not been determined. For more information regarding efficacy and safety data, see


PureVax® Feline 4 contains a lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci, each propagated in a stable cell line, plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.

Directions and dosage: Aseptically rehydrate the lyophilized vaccine with 0.5 mL of the accompanying sterile diluent, and agitate. Administer 1 dose subcutaneously or intramuscularly into healthy cats.

For primary vaccination, revaccinate with a second dose 3 to 4 weeks later. The presence of maternal antibody is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. For advice on revaccination frequency, consult your veterinarian.


Use entire contents immediately after reconstitution. Contains gentamicin as a preservative. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact a physician. Inactivate unused contents before disposal.

Store at 2-8°C (35-46°F). Do not use chemicals to sterilize syringes and needles. Do not mix with other products, except as specified on the label. Do not vaccinate pregnant cats.

For use in animals only. Sold to veterinarians only.

PUREVAX® is a registered trademark of the Boehringer Ingelheim Animal Health France SCS, used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601 USA

Tel.: 1 (888) 637-4251

VLN/PCN 124/16E8.20

Distributed in Canada by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4



25 doses

25 x 1 Dose, Lyophilized

25 x 0.5 mL, Sterile Diluent


CPN: 1028375.0

Telephone:   800-325-9167
Customer Service:   888-637-4251
Technical Service:   888-637-4251
Fax:   816-236-2717
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-11-27